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Summary  Monitoring  of  Streptococcus  pneumoniae  antibiotic  resistance  is  of
great  importance  due  to  the  frequency  of  strains  becoming  increasingly  resistant
to  antibiotics.  In  this  study,  we  report  the  antibiotic  susceptibility  of  the  serotypes
of  S.  pneumoniae  strains  isolated  from  healthy  children  aged  1—24  months  in  the
Marrakech  region  of  Morocco.  Resistance  to  penicillin  (38.7%)  was  frequently  asso-
ciated  with  resistance  to  other  antibiotics.  The  highest  rates  of  resistance  were
to  cotrimoxazole  (trimethoprim/sulfamethoxazole)  (49.3%),  erythromycin  (48.7%),
tetracycline  (37.3%),  lincomycin  (35.3%),  chloramphenicol  (32.7%)  and  ciproﬂoxacin
(24%).  Prisitinamycin  and  vancomycin  were  effective  against  all  isolated  pneumo-
coccal  strains  (100%  sensitive  strains).  Gentamycin  demonstrated  good  efﬁcacy
on  S.  pneumoniae, with  98.7%  of  strains  being  sensitive.  Multidrug  resistance
characterized  43.33%  of  all  studied  strains.  Of  the  multidrug-resistant  strains,
36.92%  were  resistant  to  erythromycin  (E),  tetracycline  (T)  and  cotrimoxazole  (Co:
sulfamethoxazole-trimethoprim)  (phenotype  ETCo,  n  =  24),  and  20%  had  decreased
susceptibility  to  beta-lactams,  erythromycin  and  cotrimoxazole  (phenotype  PECo,
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 of  S.  pneumoniae  strains  exhibited  combined  resistance  to
pe  PETCo,  n  =  19).  This  study  reports  the  status  of  resistance
.  pneumoniae  strains  in  the  Marrakech  region  of  Morocco.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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tute of  Copenhagen  (Denmark)  covering  serotypes
1, 3, 4,  6,  9,  14,  18,  19  and  23.  The  strains  that  didn  =  13).  A  total  of  29.23%
four  antibiotics  (phenoty
and  multiresistance  of  S
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Ltd.  All  rights  reserved.
Introduction
Streptococcus  pneumoniae  is a  major  pathogen
causing community  pneumonia,  otitis,  sinusitis  and
invasive severe  infections,  such  as  bacteremia  and
meningitis,  which  can  lead  to  fatal  prognoses  [1]. S.
pneumoniae  infection  is  the  primary  cause  of  bac-
terial meningitis  among  children  aged  3  months—2
years [2].
The colonization  of  the  nasopharynx  starts  from
the ﬁrst  months  of  life  and  reaches  its  peak  at  the
pre-school  age,  then  declines  progressively.  Gener-
ally, colonization  precedes  infection;  therefore,  it
is pertinent  to  enumerate  the  present  nasopharyn-
geal serogroups  and  the  circulating  and  potentially
pathogenic strains  [3].
Because  S.  pneumoniae  is  naturally  sensitive  to
most of  the  active  antibiotics  against  Gram-positive
bacteria, the  acquisition  of  antibiotic  resistance  in
S. pneumoniae  is  a  public  health  issue  [4].  Globally,
resistance  to  beta-lactams  reached  55.4%  in  France
in 2001  [5]  and  53.3%  in  Spain  in  2004  [6]. Resis-
tance  to  the  beta-lactams  comprises  more  than  50%
of cases  of  resistance  to  one  or  many  antibiotics
families [7].
Certain  serogroups  of  S.  pneumoniae  are  resis-
tant to  antibiotics  for  reasons  that  are  still
unknown. The  most  resistant  serogroups  to  beta-
lactams,  in  decreasing  order,  are  serotypes  23,  14,
9, 6,  19  and  15  [7].
Resistance  to  antibiotics  is  more  frequent  among
children  than  adults.  The  resistance  level  also
varies according  to  where  the  samples  were  taken
and remains  clearly  higher  in  the  non-invasive  sam-
ples [5],  hence  the  pertinence  of  studying  the
nasopharyngeal carriage  of  S.  pneumoniae.
In  Morocco,  few  studies  have  targeted  the  antibi-
otic resistance  of  S.  pneumoniae  strains  emanating
from  nasopharyngeal  carriage  among  healthy  chil-
dren at  an  early  age.  In  this  study,  which  is  the
continuation of  the  work  of  Bouskraoui  et  al.  [8],
we determine  the  sensitivity  of  the  S.  pneumoniae
strains to  several  antibiotics,  such  as  tetracy-
cline, erythromycin,  lincomycin,  pristinamycin,
trimethoprim-sulfamethoxazole,  chloramphenicol,
ciproﬂoxacin,  vancomycin  and  gentamycin.  We
evaluate  the  sensitivity  and  the  distribution  of
S. pneumoniae  serotypes  to  the  various  tested
n
a
sntibiotics  in  addition  to  beta-lactams.  We  report
he different  phenotypes  of  resistance  and  mul-
iresistance  of  S.  pneumoniae  strains  to  all  tested
ntibiotics.  This  study  was  conducted  prior  to  the
ntroduction  of  pneumococcal  conjugate  vaccine  to
he region.
aterials and methods
ample collection and identiﬁcation of S.
neumoniae
n  this  study,  we  included  the  S.  pneumoniae  strains
elected  from  nasopharyngeal  samples  taken  from
ealthy children,  aged  between  1  and  24  months,
een for  vaccination  follow-up  at  the  Mohammed
I University  Hospital  and  at  several  health  centers
n the  Marrakech  region  during  the  period  between
ay 2007  and  May  2009.
Samples  were  taken  from  the  medium  cornet
sing a sterilized  swab  (EUROTUBO  swab  collection,
ATALAB0819)  and  were  then  transferred  to  the
icrobiology  laboratory  of  the  Faculty  of  Medicine
nd Pharmacy  within  no  more  than  2  h.
The  swabs  were  suspended  in  0.5  mL  of  ster-
lized physiological  water.  Five  microliters  of  the
uspension  was  seeded  on  Columbia  agar  medium
CM 0331  Colombia  agar  base  Oxoid,  pH  7.3  +  0.2),
o which  5%  deﬁbrinated  sheep  blood,  nalidixic
cid (10  mg/L)  and  colistin  sulfate  (20  mg/L)  were
dded. The  medium  was  incubated  at  37 ◦C  in  an
tmosphere  with  5%  CO2 for  18  to  24  h.
The identiﬁcation  of  163  strains  of  S.  pneumo-
iae was  performed  by  evaluating  their  sensitivity
o optochin,  solubility  in  bile  and  agglutination
o latex  particles  sensitized  by  the  S.  pneumo-
iae antibodies  (Latex  slides  Pneumo-kit  from  Bio
erieux). Gram  staining  was  also  performed.
The serogrouping  of  S.  pneumoniae  strains  was
erformed  by  agglutination  on  a blade  of  sensitized
atex particles.  The  reactants  for  serotyping  were
repared  using  sera  from  the  Statens  Serum  Insti-ot agglutinate  the  tested  antiserum  were  deﬁned
s non-typable  (NT).  Strains  from  serogroup  19  were
erotyped  using  the  polymerase  chain  reaction  [9].
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Table  1  The  characteristics  of  the  antibiotics  used  in  the  study  of  the  antibioresistance  of  S.  pneumoniae  strains.
Antibiotics  Family  Disk  load  Critical  concentrations
(mg/L)
Critical  diameters
(mm)
S  R  S  R
Penicillin  G  Penicillins  10  UI  <0.06  >2  —  —
Oxacillin  5  g  <2  >2  —  —
Amoxicillin  Aminopenicillins  25  g  <0.5  >2  —  —
Tetracycline Cyclines  30  g —  —  >23  <23
Erythromycin  Macrolides  15  g —  —  >26  <24
Lincomycin  Lincosamides  15  g  —  —  >21  <17
Pristinamycin  Streptogramines  15  g  —  >19  —
Cotrimoxazole
(trimethoprim-
sulfamethoxazole)
Sulfamides  1.25/23.75  g —  —  >19  <16
Chloramphenicol  Phenicoles  30  g  —  —  >23  <23
Ciproﬂoxacin  Fluoroquinolones  5  g  —  —  >30  <19
Vancomycin  Glycopeptides  30  g  —  >17  —
Gentamycin  Aminosides  500  g  —  —  >17  <11
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Results
Serotyping of S. pneumoniae
In  a sample  of  660  children,  S.  pneumoniae  was  iso-
lated in  45.8%  cases.  The  average  age  of  children
colonized by  S.  pneumoniae  was  10.6  months  ±  6.5
(SD) (p  =  0.005).
Among  the  163  strains  serogrouped,  8  serogroups
were identiﬁed  at  frequencies  ranging  between
0.61% and  15.33%.  The  frequently  identiﬁed
serogroups  were  6,  19  F,  23,  14,  19A,  18  and
9, whereas  some  strains  were  not  serogrouped
(Fig.  1).  The  serotypes  19  not  A  and  19  not
F represented  1.84%  of  the  total  163  strains
serogrouped.  We  note  that  61  strains  did  not  agglu-
tinate the  tested  antiserum  and  were  non-typable
(NT) (Fig.  1).
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Serogroupsntibiotic resistance of S. pneumoniae
esistance  to  antibiotics  was  evaluated  by  diffusion
n Muller  Hinton  agar,  to  which  5%  sheep  blood  was
dded.  Due  to  strain  preservation  procedures,  we
ested the  antibiotic  resistance  of  150  strains  of  S.
neumoniae.
PNSP (Penicillin-Nonsusceptible  S.  pneumoniae)
as detected  by  the  use  of  oxacillin  (OXA  5  g,
26 mm).  The  minimal  inhibiting  concentrations
MICs) of  penicillin  G,  amoxicillin  and  cefotaxime
ere measured  using  the  E-Test  technique  (AB
iodisk-solana,  Sweden).
In  addition  to  the  beta-lactams,  we  also  deter-
ined the  sensitivity  of  the  S.  pneumoniae  strains
o several  other  antibiotics,  such  as  tetracycline,
rythromycin,  lincomycin,  pristinamycin,  cotrimox-
zole,  chloramphenicol,  ciproﬂoxacin,  vancomycin
nd  gentamycin  (Table  1).
Interpretations  of  the  antibiotic  diffusion  diam-
ters were  made  according  to  critical  diameters
ublished by  the  Committee  of  the  French  Micro-
iology  Society  (CA-SFM  2011).
tatistical analyses
tatistical  analysis  was  performed  using  Epi-info
000 statistical  software  developed  by  Centers  for
isease Control  and  Prevention  (CDC)  in  Atlanta,
eorgia (USA).  The  2 test  was  used  to  compare
requencies  and  p  <  0.05  was  considered  to  be  sig-
iﬁcant.
Figure  1  Distribution  of  serotypes  and  serogroups  of  S.
pneumoniae  strains  isolated  from  nasopharyngeal  car-
riage.  NT:  non-typable.
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Table  2  Susceptibility  proﬁle  of  S.  pneumoniae  strains  to  beta-lactams.
Sensitive  N  =  150  Intermediate  N  =  150  Resistant  N  =  150
Penicillin  G  92  (61.3%)  51  (34%)  7  (4.7%)
Amoxicillin  133  (88.7%)  15  (10%)  2  (1.3%)
Cefotaxime  139  (92.7%) 11  (7.3) —
S. pneumoniae proﬁles of beta-lactam
resistance
Of  the  150  S.  pneumoniae  strains  tested  for  their
antibiotic resistance,  58  (38.7%)  displayed  low  and
high resistance  to  penicillin  G  (PNSP),  with  MICs
>0.06 mg/L.  Among  these  58  strains  of  S.  pneumo-
niae,  51  strains  (87.9%)  were  poorly  resistant,  and  7
strains (12.1%)  were  highly  resistant,  including  two
strains with  MICs  equivalent  to  3  mg/mL  (Table  2
and  Fig.  2).
Considering  amoxicillin  resistance,  15  strains
(10%) were  poorly  resistant,  and  2 strains  (1.3%)
were highly  resistant  (MIC  >  2  mg/mL)  (Table  2).
No S.  pneumoniae  strains  exhibited  high  resis-
tance to  cefotaxime,  whereas  only  11  strains  (7.3%)
expressed  low  resistance  (Table  2).
Distribution of serogroups by their
sensitivity to  Penicillin G
Most  of  the  PNSP  strains  belonged  to  the  serogroups
14, 23,  19  and  6;  the  percentages  of  PNSPs  were
respectively 84.6%,  60%,  51.9%  and  20.8%.  In  con-
trast, the  strains  of  the  serogroups  4,  1,  9  and  18
were 100%  sensitive  to  Penicillin  G  (PSP)  (Fig.  3).
Fig.  4  shows  the  distribution  of  S.  pneumoniae
according to  the  level  of  resistance  to  penicillin.
Serogroup 19  presented  the  highest  level  of  resis-
tance  to  penicillin  (85.7%).
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Figure  2  Distribution  of  S.  pneumoniae  stains  with
reduced  susceptibility  to  penicillin  according  to  their
level  of  resistance.
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Figure  3  Distribution  of  S.  pneumoniae  serogroups
according  to  their  sensitivity  to  penicillin  G.  PSP:
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. pneumoniae resistance proﬁles to other
ntibiotics
able  3 shows  the  resistance  rates  (Intermedi-
te +  Resistance:  I  +  R)  of  S.  pneumoniae  strains  to
arious tested  antibiotics.  The  highest  resistances
ere, by  order  of  frequency,  49.3%  to  cotrimoxa-
ole, 48.7%  to  erythromycin,  37.3%  to  tetracycline,
5.3% to  lincomycin,  32.7%  to  chloramphenicol
nd 24%  to  ciproﬂoxacin.  Prisitinamycin  and  van-
omycin  were  effective  against  100%  of  the  strains.
entamycin  demonstrated  good  efﬁcacy  against
8.7%  of S.  pneumoniae  strains,  whereas  only  2
trains (1.3%)  were  poorly  resistant.
The resistance  rates  (I  + R)  of  PNSP  strains  were
0.7% to  cotrimoxazole,  65.52%  to  erythromycin,
8.3% to  tetracycline,  44.8%  to  lincomycin,  34.5%  to
hloramphenicol  and  91.3%  to  ciproﬂoxacin  (Fig.  5).
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igure  4  Distribution  of  the  S.  pneumoniae  serogroups
ccording  to  their  level  of  resistance  to  penicillin.
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Table  3  Susceptibility  of  S.  pneumoniae  isolates  to  antibiotics  other  than  beta-lactams.
Antibiotics  Sensitive  Intermediate  Resistant
Number  %  Number  %  Number  %
Erythromycin  57  38  20  13.3  73  48.7
Lincomycin  82  54.7  15  10  53  35.3
Tetracycline  75  50  19  12.7  56  37.3
Vancomycin  150  100  0  0
Cotrimoxazole  64  42.7  12  8  74  49.3
Ciproﬂoxacin  44  29.3  70  46.7  36  24
Chloramphenicol  93  62  8  5.3  49  32.7
Gentamycin  148  98.7 2  1.3  0
Pristinamycin 150  100  0  0
Table  4  Antibiotic-resistant  strains  of  S.  pneumoniae  according  to  their  sensitivity  to  penicillin  G.
Antibiotics  PSP  (N  =  92)  PSNP  (N  =  58)
Number  %  Number  %
Erythromycin S 37  40.2  20  34.48
I  11  12  9  15.52
R  44  47.8  29  50
Tetracycline S  45  48.9  30  51.7
I  16  17.4  3  5.2
R  31  33.7  25  43.1
Lincomycin S  50  54.3  32  55.2
I  11  12  4  6.9
R  31  33.7  22  37.9
Cotrimoxazole S  47  51.1  17  29.3
I  9  9.8  3  5.2
R  36  39.1  38  65.5
Ciproﬂoxacin S  39  42.4  5  8.6
I  31  33.7 39 67.2
R  22  23.9 14 24.1
Chloramphenicol S  55  59.8  38  65.5
I  7  7.6  1  1.7
R  30  32.6  19  32.8
Gentamycin S  90  97.8  58  100
I  2  2.2
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cS: Sensitive; I: Intermediate; R: Resistant.
The  highest  resistance  rates  of  PNSP  stains  were
5.5%,  50%,  43.1%  and  37.9%  to  cotrimoxazole,
rythromycin,  tetracycline  and  lincomycin,  respec-
ively (Table  4).elated resistance and multidrug resistance
he  frequencies  of  strains  that  had  accumulated
esistance  to  multiple  antibiotics  are  indicated
m
e
a
nn  Table  5. Of  the  150  strains  tested,  8.67%  (13
trains)  had  no  resistance  markers.  Strains  with
ne or  two  resistance  markers  represented  48%
72 strains)  of  those  strains  tested.  The  most
ommonly associated  resistances  were  to  cotri-
oxazole  and  tetracycline  (phenotype  CoT,  n  =  11),
rythromycin  and  tetracycline  (phenotype  ET,  n =  8)
nd beta-lactams  and  erythromycin  (phenotype  PE,
 =  7).
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Figure  5  Resistance  (I  +  R)  proﬁles  of  S.  pneumoniae
i
r
(
D
P
p
a
t
r
m
p
o
h
P
I
c
i
F
m
a
r
w
b
especially beta-lactams  [16].strains,  with  reduced  susceptibility  to  penicillin,  to  other
antibiotics.
Multidrug  resistance  is  deﬁned  in  S.  pneumoniae
as resistance  to  at  least  three  antibiotic  families
[8].  Multidrug  resistance  was  identiﬁed  in  43.33%
of all  studied  strains  (65  strains).  Of  these  strains,
36.92%  were  resistant  to  erythromycin,  tetracy-
cline and  cotrimoxazole  (phenotype  ETCo,  n  =  24).
Twenty percent  of  the  multidrug-resistant  strains
had decreased  susceptibility  to  penicillin,  erythro-
mycin  and  cotrimoxazole  (phenotype  PECo,  n  =  13),
whereas 29.23%  of  S.  pneumoniae  strains  exhibited
combined resistance  to  four  antibiotics  (pheno-
type PETCo,  n  =  19)  (Table  5).  The  most  common
serogroups found  in  cases  of  multidrug  resistance
were 19,  23,  14  and  6.
Fifty-one  strains  of  S.  pneumoniae  (34%)
expressed the  resistance  cassette  MLSB, which
w
(
Table  5  Multiresistance  of  S.  pneumoniae  and  the  main  re
Marker  Phenotype
1  P  
E  
T  
Co  
2  PE  
PT  
PCo  
ET  
ECo  
CoT  
Total  <  to  3  families  
3  PET  
PECo  
PTCo  
ETCo  
4  PETCo  
Total  ≥to  3  families  
P (Penicillin); E (Erythromycin); Co (Cotrimoxazole); T (TetracyclineK.  Warda  et  al.
nvolves  combined  resistance  to  Macrolide  (eryth-
omycin),  Lincomycine  and  Streptogramine  B
Pristinamycin).
iscussion
neumococcal  infection  is  responsible  for  severe
athologies  found  speciﬁcally  at  the  extremes  of
ge. Because  colonization  precedes  infection  [10],
he studies  of  carriage  and  antibiotic  resistance
epresent a major  interest  in  providing  early  infor-
ation on  circulating  serotypes  [11,12].
Beta-lactams  are  used  for  the  treatment  of  S.
neumoniae  infections.  For  this  family  of  antibi-
tics,  the  resistance  is  associated  with  an  important
eterogeneity  in  its  expression.  The  prevalence  of
NSP resistance  varies  from  one  country  to  another.
n our  study,  the  PNSP  rate  is  38.7%.  In  other
ountries, the  PNSP  rates  are  53.5%  in  Spain,  83.5%
n Uganda  [6,13], 48%  in  Tunisia  [14]  and  50%  in
rance [4].
The  disparity  in  PNSP  rates  in  various  countries
ay be  explained  by  the  different  usage  rates  for
ntibiotics  in  the  treatment  of  non-invasive  respi-
atory infections  [4,15].  In  fact,  the  studies  that
ere performed  in  Europe  revealed  a  correlation
etween PNSP  rates  and  antibiotics  consumption,In  our  study,  12.1%  of  the  S.  pneumoniae  strains
ere highly  resistant  to  penicillin  G;  the  majority
85.7%) of  these  strains  belonged  to  serogroup  19.
sistance  phenotypes.
Number  of  strains  Major  serogroups
7  19,  23,  14
18  19,  14,  6
4  19,  6,  NT
5  19,  23,  14
7  6,  19,  23
0
7  14,  23
8  19,  14
5  19,  23,  14
11  14,  19,  6
72
3  23,  6,  19
13  19,  6,  14
6  19,  14
24  23,  6
19  14,  6,  19
65
); NT (Non-typable).
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sntibiotic  resistance  and  serotype  distribution  
The  lowest  rates  of  resistance  among  the  studied
trains were  10%  to  amoxicillin  and  7.33%  to  cefo-
axime.  High  resistance  to  amoxicillin  was  present
n 2  strains  (1.3%).  In  France  in  2007,  the  per-
entages of  strains  that  expressed  low  resistance
o penicillin,  amoxicillin  and  cefotaxime  were,
espectively, 9.8%,  29.3%  and  61%  [15]. This  study
ndicates  that  high  levels  of  resistance  to  amoxi-
illin or  cefotaxime  were  not  detected  [15].  In  our
tudy, no  strains  that  were  sensitive  to  penicillin  G
ere resistant  to  any  other  beta-lactams.
Resistance to  beta-lactams  is  generally  cou-
led with  resistance  to  other  antibiotics,  such  as
acrolides,  cyclines  and  chloramphenicol  [17,18].
n our  study,  the  resistance  rates  of  S.  pneumo-
iae isolates  to  other  antibiotic  families  were  quite
igh. Thus,  the  I +  R  resistance  rate  to  erythro-
ycin was  62%.  This  rate  was  close  to  the  rates
bserved in  France,  Italy  and  Tunisia,  where  resis-
ance rates  have  reached  60%,  65.5%  and  68.4%,
espectively [19—21]. The  resistance  rate  detected
n this  study  was  higher  than  the  rate  observed  in
pain in  non-invasive  strains  (44%)  [18]  and  in  India
10.9%) [22]  but  was  less  than  the  rate  observed
n Taiwan  (90.5%)  [11].  Moreover,  the  strains  that
ad a  high  level  of  resistance  to  penicillin  were
esistant to  erythromycin.  In  our  study,  49.3%  of
. pneumoniae  strains  expressed  high  resistance
o cotrimoxazole.  This  rate  is  much  higher  than
he 9.9%  resistance  observed  in  Tunisia  [21]  and  is
ess than  the  rates  observed  in  India  (81.9%)  [26],
aiwan (66.3%)  [11]  and  the  Ivory  Coast  (84.3%)
23].  Concerning  chloramphenicol,  the  I  +  R  rate  of
esistance  in  our  study  (38%)  was  comparable  to  the
ate observed  in  Tunisia  (44.1%)  [21]  but  was  higher
han the  rates  observed  in  the  Ivory  Coast  (8%)  [23]
nd  Italy  (10.7%)  [24].  The  rate  of  resistance  to
hloramphenicol  was  less  than  the  rate  observed
n Vietnam  (60%)  [25].  Concerning  tetracycline,  our
 +  R  resistance  rate  was  50%.  This  resistance  was
igher  than  the  rate  observed  in  Italy  (30.6%)  [24]
nd  less  than  the  rates  observed  in  Taiwan  (82.1%)
11],  the  Ivory  Coast  (76.4%)  [23],  Vietnam  (63%)
25]  and  India  (60.8%)  [22].  The  resistance  rate  of
iproﬂoxacin  (I  +  R)  (70.7%)  was  less  than  the  rate
bserved  in  France  (97.8%)  [4].
Prisitinamycin,  vancomycin  and  gentamycin
emonstrated  good  efﬁcacy  against  S.  pneumoniae
trains and  are  therefore  useful  alternative  agents
or the  treatment  of  infections  caused  by  the  strains
hat are  resistant  to  other  drugs.
The resistance  to  other  antibiotics  within  the
NSP strains  was  higher  compared  to  Penicillin-
usceptible Pneumococci  (PSP)  strains  (Table  4).
NSP resistance  rates  were  65.5%,  50%  and  43.1%,
espectively,  for  cotrimoxazole,  erythromycin  and
o
t
o
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etracycline  compared  to  39.1%,  47.8%  and  33.7%
or PSPs.  Dall  et  al.  [26]  reported  PNSP  resis-
ance rates  of  90.9%,  61.8%  and  30.5%,  respectively,
o erythromycin,  cotrimoxazole  and  tetracycline
ersus 43.9%,  21.5%  and  22.4%  for  PSPs  [26].
However, 43.33%  of  pneumococcal  strains  were
esistant  to  at  least  three  different  classes  of
ntibiotics. The  phenotypes  that  combined  resis-
ance to  beta-lactams,  macrolides  and  cyclines
epresented 20%  of  the  tested  isolates.  This  rate
s relatively  weak  when  compared  to  the  rate
eported in  France  (75%)  [4]. The  rate  of  the  PETCo
henotype  (29.23%)  was  higher  compared  to  the
ate observed  in  the  Atale  study  (17.3%)  [4].
The problem  of  multidrug-resistant  S.  pneu-
oniae strains  is  increasingly  worrying.  Because
ore than  half  of  the  isolates  were  resistant  to
t least  one  antimicrobial  agent,  drug-resistant
neumococci  have  become  an  important  clini-
al problem.  Selecting  effective  treatments  for
atients  with  multi-resistant  pneumococcal  infec-
ions is  becoming  increasingly  difﬁcult.  The  new
eneration  of  macrolides  and  ﬂuoroquinolones  are
ow widely  used  in  the  treatment  of  pneumococ-
al infections  and  in  the  empirical  treatment  of
espiratory infections.  Unfortunately,  our  data  indi-
ate a  fairly  high  rate  of  resistance  to  erythromycin
nd ciproﬂoxacin,  and  macrolide  resistance  can  be
nferred from  isolates  that  are  sensitive  to  erythro-
ycin  [27].
onclusion
valuating  the  multiple  antibiotic  resistance  of
. pneumoniae  is  an  important  tool  for  following
asopharyngeal  carriage  and  the  surveillance  of the
volution of  pneumococcal  strains  in  children.
The introduction  of  the  7-valent  and  the  10-
alent pneumococcal  vaccines  in  several  countries
as been  associated  with  a signiﬁcant  decrease
n the  incidence  of  invasive  infections  [24,28,29];
owever, these  vaccines  are  associated  with  resis-
ance in  some  cases  [30].  The  epidemiological
hanges  in  pneumococcal  serotypes  require  moni-
oring so  as  not  to  overlook  the  reappearance  of
ntibiotic  resistance  within  certain  serotypes  [30].
These measures  should  be  undertaken  with
he introduction  of  the  new  13-valent  conju-
ate vaccine.  The  establishment  of  a preventive
trategy against  pneumococcal  invasive  infections
hould  be  consolidated  with  prescription  control
f antibiotics.  This  strategy  will  assess  the  par-
icular  beneﬁts  of  prescription  control  in  terms
f mortality  and  serious  sequelae  of  pneumococ-
al meningitis,  monitoring  the  fate  of  replacement
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serotypes  in  invasive  infections  and  the  develop-
ment of  their  antibiotic  resistance  proﬁles.
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